<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02872545</url>
  </required_header>
  <id_info>
    <org_study_id>2016-A00378-43</org_study_id>
    <nct_id>NCT02872545</nct_id>
  </id_info>
  <brief_title>Influence of Patient Position on Attenuation Artifacts Observed in D-SPECT Camera Myocardial Tomoscintigraphy</brief_title>
  <acronym>D-SPECT BIKER</acronym>
  <official_title>Influence of Patient Position on Attenuation Artifacts Observed in D-SPECT Camera Myocardial Tomoscintigraphy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to compare percentages of myocardial segments showing attenuation in patients&#xD;
      in forward tilted position (biker position) or 2 conventional positions (dorsal decubitus or&#xD;
      semi sitting) at acquisition with D-SPECT camera in myocardial tomoscintigraphy.&#xD;
&#xD;
      The hypothesis is that the percentage of myocardial segments with attenuation is&#xD;
      significantly lower when acquisitions are made in forward tilted position (biker position).&#xD;
&#xD;
      The secondary purpose is to restrict this analysis to 3 cardiac regions most subject to&#xD;
      attenuation artifacts (anterior, apical and inferobasal regions).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Myocardial perfusion tomoscintigraphy is a very used technique for diagnosis and&#xD;
      characterization of abnormalities of stress and rest myocardial perfusion (ischemia,&#xD;
      infarction).&#xD;
&#xD;
      A common problem is attenuation artifacts that are due to tissue interposition attenuating&#xD;
      radiation from some cardiac regions. These artifacts originate activity decreasing and thus&#xD;
      perfusion abnormalities potentially in all walls of left ventricle, especially the inferior&#xD;
      wall in men (attenuation by sub-diaphragmatic organs) and the anterior wall in women&#xD;
      (attenuation by mammary glands). These artifacts are observed in rest and stress acquisitions&#xD;
      and can lead to a wrong diagnosis of infarction.&#xD;
&#xD;
      Attenuation artifacts can be identified with analysis of contraction kinetics with&#xD;
      &quot;gated-SPECT&quot; (normal kinetics and thus discordant with aspect of infarction). With D-SPECT&#xD;
      camera some artifacts can be prevented with a 30-35° forward tilted position of acquisition.&#xD;
      This position, also called biker position, can take cardiac area away from sub-diaphragmatic&#xD;
      structures. It can also reduce the distance between heart and detection surface of camera and&#xD;
      limit respiratory movements of thoracic wall.&#xD;
&#xD;
      In this study, patients with abnormal results at stress myocardial perfusion tomoscintigraphy&#xD;
      will undergo a rest tomoscintigraphy. Acquisition will be done in forward tilted position and&#xD;
      in one of 2 other positions: dorsal decubitus or semi sitting.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of myocardial segments classified with attenuation artifact</measure>
    <time_frame>day 0</time_frame>
    <description>With infarction aspect but normal contraction kinetics in Gated-SPECT analysis.&#xD;
Left ventricle is divided in 17 segments according to American Heart Association.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of myocardial segments classified with attenuation artifact in anterior region</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of myocardial segments classified with attenuation artifact in apical region</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of myocardial segments classified with attenuation artifact in inferobasal region</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Attenuation Artifact</condition>
  <condition>Myocardial Tomoscintigraphy</condition>
  <condition>Patient Position</condition>
  <arm_group>
    <arm_group_label>forward tilted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with abnormal results at stress myocardial perfusion tomoscintigraphy will undergo a rest tomoscintigraphy. Acquisition will be done in forward tilted position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>semi sitting</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with abnormal results at stress myocardial perfusion tomoscintigraphy will undergo a rest tomoscintigraphy. Acquisition will be done in semi sitting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dorsal decubitus</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with abnormal results at stress myocardial perfusion tomoscintigraphy will undergo a rest tomoscintigraphy. Acquisition will be done in dorsal decubitus</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rest tomoscintigraphy in forward tilted</intervention_name>
    <description>Rest tomoscintigraphy in forward tilted position</description>
    <arm_group_label>dorsal decubitus</arm_group_label>
    <arm_group_label>forward tilted</arm_group_label>
    <arm_group_label>semi sitting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rest tomoscintigraphy in semi sitting position</intervention_name>
    <description>Rest tomoscintigraphy in forward tilted position, followed by a second rest tomoscintigraphy in semi sitting position, after max 30 min</description>
    <arm_group_label>forward tilted</arm_group_label>
    <arm_group_label>semi sitting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rest tomoscintigraphy in dorsal decubitus position</intervention_name>
    <description>Rest tomoscintigraphy in forward tilted position, followed by a second rest tomoscintigraphy in semi sitting position, after max 30 min</description>
    <arm_group_label>dorsal decubitus</arm_group_label>
    <arm_group_label>forward tilted</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Affiliation to social security&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
          -  Previous clinical examination authorizing patient to undergo tomoscintigraphy&#xD;
&#xD;
          -  Patient with abnormal results of stress tomoscintigraphy and needing a rest&#xD;
             tomoscintigraphy&#xD;
&#xD;
          -  Patient with sinus and regular cardiac rhythm&#xD;
&#xD;
          -  Patient with stable clinical status (without signs of unstable cardiac or coronary&#xD;
             failure, without uncontrolled hypertension under treatment)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women of childbearing potential without effective contraception&#xD;
&#xD;
          -  Evolutive pregnancy&#xD;
&#xD;
          -  Breastfeeding patient&#xD;
&#xD;
          -  Contraindication to tomoscintigraphy&#xD;
&#xD;
          -  Patient with history of hypersensibility to tomography radiotracer STAMICIS® or one of&#xD;
             components&#xD;
&#xD;
          -  Patient in life-and-death emergency&#xD;
&#xD;
          -  Patient with history of disorders possibly interfering with contractility&#xD;
&#xD;
          -  Patient with normal results of stress tomoscintigraphy&#xD;
&#xD;
          -  Person under legal protection or incapable to consent&#xD;
&#xD;
          -  Person deprived of liberty by judicial or administrative decision&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathieu PERRIN, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Médecine Nucléaire - CHRU de Nancy-Brabois - Vandoeuvre Lès Nancy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu PERRIN, Dr</last_name>
    <email>matperrin@yahoo.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Médecine Nucléaire - CHRU de Nancy-Brabois</name>
      <address>
        <city>Vandoeuvre Lès Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>August 16, 2016</study_first_submitted>
  <study_first_submitted_qc>August 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2016</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

